Why it was recalled
Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet
Product description
Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.
Lot numbers, UPCs & expiration codes
Lot #: 2402101UR, Exp 02/28/2027
Where it was sold
Nationwide USA.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0208-2025
- Classification
- Class III
- Status
- Completed
- Recall initiated
- Jan 16, 2025
- FDA report date
- Jan 29, 2025
- Quantity
- 1380 bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Appco Pharma LLC
Original FDA data
Every field from FDA enforcement report D-0208-2025, exactly as published.
Show all FDA fields
- City
- Piscataway
- State
- NJ
- Status
- Completed
- Country
- United States
- Event ID
- 96128
- Address
- 262 Old New Brunswick Rd Unit N
- Code information
- Lot #: 2402101UR, Exp 02/28/2027
- Postal code
- 08854-3756
- Report date
- Jan 29, 2025
- Product type
- Drugs
- Recall number
- D-0208-2025
- Classification
- Class III
- Recalling firm
- Appco Pharma LLC
- Product quantity
- 1380 bottles
- Reason for recall
- Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.
- Distribution pattern
- Nationwide USA.
- Recall initiation date
- Jan 16, 2025
- Initial firm notification
- Letter
- Center classification date
- Jan 23, 2025